ABMT: Attention Bias Modification Treatment for Anxious Youth

Sponsor
Weill Medical College of Cornell University (Other)
Overall Status
Terminated
CT.gov ID
NCT01979263
Collaborator
(none)
5
2
2
39.6
2.5
0.1

Study Details

Study Description

Brief Summary

The purpose of this project is to study the feasibility and efficacy of attention bias modification treatment (ABMT) in a randomized-controlled sample of anxious youth.

Condition or Disease Intervention/Treatment Phase
  • Other: Attention Bias Modification Computer Task
  • Other: Placebo Computer Task
N/A

Detailed Description

The purpose of this study is to determine whether or not ABMT computer-based interventions can be used successfully to help reduce anxiety disorder symptoms in children ages 7 to 17. ABMT is different from most other treatments for anxiety because it is not medication or talk therapy. ABMT is a computerized attention training program designed to change how we direct our attention. The purpose of ABMT is to set in place attentional patterns that do not lead to excessive anxiety. Research has shown that it may be highly effective in reducing anxiety. The Intervention will be composed of your child engaging in 6 brief weekly ABMT sessions. The sessions seem like a repetitive computer game.

This study is appropriate for children who may have symptoms of an anxiety disorder, like Generalized Anxiety Disorder, Separation anxiety Disorder, Social Anxiety Disorder, Specific Phobia, or Obsessive-Compulsive Disorder." Children who appear eligible for the study may attend a diagnostic evaluation and assessment if they meet study criteria.

If a child is eligible for the study, he or she will be randomly assigned to either get an "active" form of the computer program or a "placebo" or inactive form of the computer program. The child will come to six weekly appointments at our clinic that are quite brief, about a half hour. Then the child will have an evaluation after the last of the six appointments to see if the computer intervention was helpful in reducing his or her anxiety. We'd then wait a month and then have a final evaluation to see if the child's anxiety has changed over that period of time.

Study Design

Study Type:
Interventional
Actual Enrollment :
5 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Attention Bias Modification Treatment for Anxious Youth
Study Start Date :
Oct 1, 2013
Actual Primary Completion Date :
Jan 17, 2017
Actual Study Completion Date :
Jan 17, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Attention Bias Modification

Attention Bias Modification computer task

Other: Attention Bias Modification Computer Task
Computer task aimed at actively modifying attention bias

Placebo Comparator: Placebo Computer Task

Placebo computer task

Other: Placebo Computer Task
Computer task that does not actively modify attention bias

Outcome Measures

Primary Outcome Measures

  1. Change in clinical severity ratings on Anxiety Disorder Interview Schedule-Child and Parent Version [after a 6-week intervention and 4-week no-treatment follow-up]

Secondary Outcome Measures

  1. Variation in genes associated with treatment response [week 1]

    We will study allelic variation in a gene that has been associated with treatment response to anxiety interventions, the serotonin-transporter-linked promoter region (5-HTTLPR)

Eligibility Criteria

Criteria

Ages Eligible for Study:
7 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis on Anxiety Disorders Interview Schedule for Diagnostic and Statistical Manual-IV Child and Parent versions of Separation Anxiety Disorder, Social Phobia, Specific Phobia, Obsessive-Compulsive Disorder, or Generalized Anxiety Disorder

  • Age 7 to 17

Exclusion Criteria:
  • Posttraumatic stress disorder or primary diagnosis of major depressive disorder

  • Seizure disorder

  • Current treatment with psychotropic medication

  • Multiple chronic learning disabilities and/or conduct problems

Contacts and Locations

Locations

Site City State Country Postal Code
1 Payne Whitney Manhattan Child Division New York New York United States 10065
2 New York Presbyterian Hospital--Westchester Division White Plains New York United States 10605

Sponsors and Collaborators

  • Weill Medical College of Cornell University

Investigators

  • Principal Investigator: Megan H Feltenberger, PhD, Weill Medical College of Cornell University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT01979263
Other Study ID Numbers:
  • 1207012686R001-IRB
First Posted:
Nov 8, 2013
Last Update Posted:
Jul 30, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 30, 2019